CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Genitourinary Cancer » Prostate Cancer

ONCOLOGY. Vol. 25 No. 7
RESEARCH REPORT 

Link Between Sexual Orientation and Cancer

By Anna Azvolinsky, PhD | May 12, 2011

While populations are often analyzed by age, sex, and race with respect to cancer risk and cancer outcomes, sexual orientation has previously not been studied as a factor for either cancer incidence or cancer outcome. A study published in the journal Cancer on May 9, 2011 has now specifically examined the cancer survivorship of the gay, lesbian, and bisexual population (DOI: 10.1002/cncr.25950). The study authors found that cancer outcomes differ based on sexual orientation.

While there is a dearth of data on cancer survivorship among gay/lesbian/bisexual populations, it has been suggested that these populations generally engage in behaviors that are associated with greater cancer risk. These risk factors include a higher incidence of obesity and alcohol(Drug information on alcohol) consumption among the lesbian population and a higher rate of smoking among gay men, lesbians, and bisexuals. Furthermore, recent studies have shown that same-sex sexual contact is linked to a higher incidence of head and neck and anal cancers. However, the question of cancer survivorship with respect to sexual orientation has not been well-studied, since most cancer surveillance studies do not record this statistic.

Methods and results

Ulrike Boehmer, PhD and her colleagues from Boston University used pooled data from the California Health interview survey from 2001, 2003, and 2005 to examine cancer prevalence among men and women by sexual orientation. Additionally, the authors used self-reported health surveys to analyze cancer survivorship based on sexual orientation. The data included data from 3,690 men and 7,252 women who had reported a cancer diagnosis as adults. This is the largest state health survey executed in the United States.

The study found a significant difference in cancer outcomes among heterosexual men compared with homosexual men. Homosexual men were found to be 1.9 times more likely to self-report a cancer diagnosis than were heterosexual men. No differences in cancer survivorship were found between the two groups. Homosexual men reported a significantly lower frequency of prostate cancer—one-third the frequency of other men. Homosexual and bisexual men had a greater incidence of all other cancers.

Although homosexual women did not have a higher incidence of cancer, these women did report lower overall health as cancer survivors compared to heterosexual women. Unilke the male population, which did not differ in self-reported health based on sexual orientation, lesbian cancer survivors were 2.0 times and bisexual women survivors were 2.3 times more likely to report poor or fair health compared with their heterosexual cancer survivor counterparts.

The study found that bisexual women had a two-fold higher prevalence of cervical cancer compared with other women. Uterine cancer was most prevalent among homosexual women, and the incidence of all other cancers was higher among heterosexual women.

Follow up questions and implications

Follow-up studies should be prospective in nature in order to address self-reporting bias. Additionally, future studies should be expanded geographically to include cancer survivors from across the United States and should not rely on self-reporting data.

Many questions should be addressed in the extension of this research. Whether homosexual men are reporting more cancer survivorship compared with heterosexual men because more have been diagnosed with cancer or because more are surviving their diagnosis is unclear from this study. The frequency of cancer diagnoses among heterosexual women compared to homosexual women is also unclear.

This study has implications for US cancer control efforts, including disease management and prevention of secondary cancers by the Centers for Disease Control and Prevention as well as the National Cancer Institute and the American Cancer Society. Approximately 4% of the US population are cancer survivors, and knowing who is included in this population, as the authors point out, is important for providing survivorship care, including psychosocial and medical care. Knowing the make-up of the cancer survivorship population can only aid public health and healthcare agencies in providing for specific needs of subsets of this population, including lesbian, gay, and bisexual survivors.

The first author of the study highlighted that the higher incidence of cancers among gay men found in the study should stimulate planning and execution for better screening, education, and primary prevention among this population by public health agencies. “Because more gay men report as cancer survivors, we need foremost programs for gay men that focus on primary cancer prevention and early cancer detection. Because more lesbian and bisexual women than heterosexual women with cancer report that they are in poor health, we need foremost programs and services that improve the well-being of lesbian and bisexual cancer survivors,” said Dr. Boehmer.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

New AUA Guidelines for Prostate Cancer Screening
May 17, 2013
Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
May 17, 2013
Radium-223 Gets Early FDA Nod for Bone Mets in Castration-Resistant Prostate Cancer
May 16, 2013
Rising PSA Level in a 46-Year-Old Man
ONCOLOGY,  May 15, 2013
Secondary Hormone Therapy for Castration-Resistant Prostate Cancer
ONCOLOGY,  May 15, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Prostate Cancer
Evidence on Prostate Cancer
Guidelines on Prostate Cancer
Patient Education on Prostate Cancer
Clinical Trials on Prostate Cancer
Practical Articles on Prostate Cancer
Research and Reviews on Prostate Cancer
All "Prostate Cancer" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy